[1]Biftu,Tesfaye;Sinha-Roy,Ranabir;Chen,Ping;Qian,Xiaoxia;Feng,Dennis;Kuethe,JeffreyT.;Scapin,Giovanna;Gao,YingDuo;Yan,Youwei;Krueger,Davida;Bak,Annette;Eiermann,George;He,Jiafang;Cox,Jason;Hicks,Jacqueline;Lyons,Kathy;He,Huaibing;Salituro,Gino;Tong,Sharon;Patel,Sangita;Doss,George;Petrov,Aleksandr;Wu,Joseph;Xu,ShiyaoSherrie;Sewall,Charles;Zhang,Xiaoping;Zhang,Bei;Thornberry,NancyA.;Weber,AnnE.[JournalofMedicinalChemistry,2014,vol.57,#8,p.3205-3212]
[2]CurrentPatentAssignee:SUNPHARMACEUTICALINDUSTRIESLIMITED-WO2017/81590,2017,A1Locationinpatent:Page/Pagecolumn13;28
[3]CurrentPatentAssignee:SICHUANCHECOPHARMACEUTICALTECH-CN111793071,2020,ALocationinpatent:Paragraph0045-0046;0048-0049;0051-0052;0054-0055;0057
[4]CurrentPatentAssignee:SHANGHAIBOCIMEDPHARMACEUTICALCOLTD-CN106674227,2017,ALocationinpatent:Paragraph0072;0073
[5]CurrentPatentAssignee:MERCK&COINC-US2010/120863,2010,A1Locationinpatent:Page/Pagecolumn24
[6]Chung,JohnY.L.;Scott,JeremyP.;Anderson,Camille;Bishop,Brian;Bremeyer,Nadine;Cao,Yang;Chen,Qinghao;Dunn,Robert;Kassim,Amude;Lieberman,David;Moment,AaronJ.;Sheen,Faye;Zacuto,Michael[OrganicProcessResearchandDevelopment,2015,vol.19,#11,p.1760-1768]
[7]CurrentPatentAssignee:MERCK&COINC-US9181262,2015,B2Locationinpatent:Page/Pagecolumn14
[8]CurrentPatentAssignee:MERCK&COINC-US9181262,2015,B2Locationinpatent:Page/Pagecolumn14
[9]CurrentPatentAssignee:MERCK&COINC-WO2016/14324,2016,A1Locationinpatent:Page/Pagecolumn25-26
[10]CurrentPatentAssignee:HANGZHOUPUSHAIPHARMACEUTICALTECHNOLOGYCOLTD(unclear)-CN106928228,2017,ALocationinpatent:Paragraph0123;0124
[1]Patent:WO2013/3249,2013,A1
1226781-44-7
[1]CurrentPatentAssignee:MERCK&COINC-WO2013/3249,2013,A1Locationinpatent:Page/Pagecolumn15;16
[1]Biftu,Tesfaye;Sinha-Roy,Ranabir;Chen,Ping;Qian,Xiaoxia;Feng,Dennis;Kuethe,JeffreyT.;Scapin,Giovanna;Gao,YingDuo;Yan,Youwei;Krueger,Davida;Bak,Annette;Eiermann,George;He,Jiafang;Cox,Jason;Hicks,Jacqueline;Lyons,Kathy;He,Huaibing;Salituro,Gino;Tong,Sharon;Patel,Sangita;Doss,George;Petrov,Aleksandr;Wu,Joseph;Xu,ShiyaoSherrie;Sewall,Charles;Zhang,Xiaoping;Zhang,Bei;Thornberry,NancyA.;Weber,AnnE.[JournalofMedicinalChemistry,2014,vol.57,#8,p.3205-3212]
[1]Patent:CN107652291,2018,A.Locationinpatent:Paragraph0024;0042;0044;0045
[2]JournalofMedicinalChemistry,2014,vol.57,p.3205-3212
[3]OrganicProcessResearchandDevelopment,2015,vol.19,p.1760-1768
[4]Patent:US9181262,2015,B2
Title: Omarigliptin (MK-3102): a novel long-acting DPP-4 inhibitor for once-weekly treatment of type 2 diabetes.
Journal: Journal of medicinal chemistry 20140424
Title: Ayoub BM, et al. Repositioning of Omarigliptin as a once-weekly intranasal Anti-parkinsonian Agent. Sci Rep. 2018 Jun 12;8(1):8959.
Title: Li X, et al. Omarigliptin alleviates cognitive dysfunction in Streptozotocin-induced diabetic mouse. Bioengineered. 2022 Apr;13(4):9387-9396.
Title: Ayoub BM, et al. Repurposing of Omarigliptin as a Neuroprotective Agent Based on Docking with A2A Adenosine and AChE Receptors, Brain GLP-1 Response and Its Brain/Plasma Concentration Ratio after 28 Days Multiple Doses in Rats Using LC-MS/MS. Molecules. 2021 Feb 8;26(4):889.
